ABSTRACT. A cDNA encoding canine mucosal addressin cell adhesion molecule-1 (MAdCAM-1) was cloned. The entire open reading frame of canine MAdCAM-1 cDNA comprises 1137 bp, corresponding to 378 amino acid residues. The deduced amino acid sequence of canine MAdCAM-1 was 55.2%, 53.7%, and 52.4% identical to rat, mouse, and human MAdCAM-1, respectively. Canine MAdCAM-1 appeared to contain two immunoglobulin-like domains at the N-terminus, followed by a mucin-like domain and a third immunoglobulin-like domain. The structures of the dog, rat, and mouse proteins are likely similar because all of the cysteine residues in the immunoglobulin-like domains were conserved. Canine MAdCAM-1 mRNA was confirmed to express extremely in the mesenteric lymph node by RT-PCR. KEY WORDS: canine, cDNA cloning, MAdCAM-1.
Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) is a member of the immunoglobulin supergene family expressed on the high endothelial venule of mucosal lymphoid tissues, such as mesenteric lymph nodes and Peyer's patches. This adhesion molecule participates in the selective homing of lymphocytes to gut-associated lymphoid tissues [1] . MAdCAM-1 of the rat and mouse has two immunoglobulin-like domains at the N-terminus, followed by a mucin-like domain and a third immunoglobulin-like domain with homology to IgA or MHC class I [5, 7] . Two N-terminal immunoglobulin-like domains participate in binding to integrin α 4 β 7 in lymphocytes [1, 3, 4, 8, 9] . The mucin-like domain has many glycosylation sites and binds L-selectin [1, 2] . The human MAdCAM-1, however, lacks the third immunoglobulin-like domains [9] .
The increased expression of MAdCAM-1 at inflammatory foci associated with human inflammatory bowel disease (IBD) (ulcerative colitis and Crohn's disease) is reported, suggesting the participation to pathogenesis of IBD [6] . Although IBD is a common cause of chronic gastrointestinal disease in dogs, the pathogenesis is not known. To investigate the physiological function and the possible roles in various inflammatory diseases of dogs, we cloned the canine MAdCAM-1 gene and examined its expression in various canine tissues.
Total RNA for cloning canine MAdCAM-1 was extracted from a normal canine mesenteric lymph node using an RNeasy Mini Kit (Qiagen, CA, U.S.A.). Total RNA was treated with a DNA-free TM kit (Ambion, TX, U.S.A.) to remove contaminating DNA. A cDNA sample was transcribed using an Omniscript TM Reverse Transcriptase kit (Qiagen) and an oligo (dT) 16 primer. Degenerate primers to amplify a central region of the canine MAdCAM-1 cDNA were constructed based on conserved amino acid sequences between human (GeneBank accession no. NM130761) and mouse MAdCAM-1 genes (GeneBank accession no. NM013591): forward primer, 5'-GGCGKGGYCKGGACACC-3' and reverse primer, 5'-CATSGTG RCCTGGCAGTR-RAGGGC-3'. Using these primers, a central region sequence of canine MAdCAM-1 cDNA was amplified from canine mesenteric lymph node cDNA by polymerase chain reaction (PCR) using an Advantage TM -GC 2 PCR kit (Clontech, CA, U.S.A.) according to the manufacturer's instructions. PCR was carried out as follows: 94°C for 3 min; 35 cycles of 94°C for 30 s, 60°C at 30 s, and 72°C for 90 s; and 72°C for 7 min. The PCR product from the partial canine MAdCAM-1 gene was cloned into the pCR2.1 vector using a TA Cloning kit (Invitrogen, CA, U.S.A.). Competent cells (INVaF'; Invitrogen) were transformed using ligation mixture. Bacterial cultures were grown in LB broth, and plasmid DNAs were extracted from the bacteria using a Quantum prep kit (Bio-Rad, CA, U.S.A.). PCR products were sequenced using a BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, CA, U.S.A.) with an ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
A series of 5'-and 3'-rapid amplification of cDNA ends (RACE) reactions was employed to determine the full length of cDNA sequences for the canine MAdCAM-1. 5'-and 3'-RACE reactions were carried out according to manufacturers' instructions using a 5'/3' RACE Kit (Roche Diagnostic GmbH, Mannheim, Germany) and a GeneRacer TM Kit (Invitrogen), respectively. The sequences of genespecific primers for the 5' and 3'f RACE methods were designed based on the central region sequences of canine MAdCAM-1 cDNA clones. PCR products from the 5'-and 3'-sides of canine MAdCAM-1 cDNA were sequenced as described above. To confirm that the gene cloned in this study was linear, the primers were designed to produce three overlapping fragments.
Combining the sequences of partial overlapping cDNA fragments obtained in this study, we determined a linear sequence of 1350 bp corresponding to canine MAdCAM-1 cDNA. This sequence contained all 1137 bp of the open reading frame, corresponding to 378 amino acid residues (GeneBank accession no. AB211528). Signal peptides at the N-terminus and the transmembrane region near the Cterminus were identified as clusters of hydrophobic amino acids. A canonical polyadenylation signal, AATAAA, is located at position 1294. The nucleotide sequence encoding the open reading frame of canine MAdCAM-1 cDNA was 65.7%, 64.8%, and 69.0% identical with those of rat, mouse, and human MAdCAM-1 cDNAs, respectively. The deduced amino acid sequence of canine MAdCAM-1 was 55.2%, 53.7%, and 52.4% identical with those of rat, mouse, and human MAdCAM-1, respectively.
Because the human MAdCAM-1 lacks the third immunoglobulin-like domains, sequences of canine MAdCAM-1 were divided into two parts and compared. Figure 1A shows a comparison of the first and the second immunoglo- was conserved in the first domain of MAdCAM-1 from all species [10] . Also, all cysteine residues in the first and the second immunoglobulin-like domains of canine MAdCAM-1 were conserved, suggesting that the conformations of these domains in the canine protein are similar to those from other species.
Comparisons of the mucin-like and the third immunoglobulin-like domains of the dog, rat, mouse, and human MAd-CAM-1 is shown in Fig. 1B . The amino acid sequences of this region showed low similarity among these species, and the deduced amino acid sequences of the region containing the mucin-like and third immunoglobulin-like domains were 52.4%, 48.0%, and 38.5% identical to those of rat, mouse, and human MAdCAM-1, respectively. The mucinlike domain contains many putative glycosylation sites and has been reported to participate in the binding of L-selectin [2] . The cysteine residues in the loop of the third immunoglobulin-like domains were conserved between the dog, rat, and mouse but not the human MAdCAM-1.
Southern hybridization analysis was carried out to confirm the MAdCAM-1 gene in the genomic DNA of dogs, and determined two distinct bands in BamHI digests of genomic DNA from dogs.
Expression of MAdCAM-1 mRNA in normal canine tissues was examined by reverse transcription-PCR (RT-PCR). Total RNA samples were extracted from stomach, duodenum, colon, mesenteric lymph node, peripheral lymph node, liver, spleen, kidney, lung, and urinary bladder tissues, obtained from a healthy beagle dog. The cDNA samples were prepared as described above. As an internal control, canine glycerardehyde-3-phosphate dehydrogenase (GAPDH) (GeneBank accession no. AB038240) mRNA was amplified in each sample. Sequences of primers we used were follows: forward primer, 5'-GAGGCCCTCTC-CTTGTCTCT-3' and reverse primer, 5'-ACCTGGAA-CAGCAGGTCCTC-3' for canine MAdCAM-1, forward primer, 5'-GGAGAAAGCTGCCAAATATG-3' and reverse primer, 5'-ACCAGGAAATGAGCTTGACA-3' for canine GAPDH. PCR was performed using AmpliTaq Gold DNA polymerase (Applied Biosystems) and the following conditions: 95°C for 9 min; 50 (MAdCAM-1) or 30 (GAPDH) cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min; and 72°C for 7 min. PCR products were separated by electrophoresis on a 3% agarose gel and visualized by staining with ethidium bromide. The amplified DNA fragments from the RT-PCR were sequenced to confirm that they were products of the canine MAdCAM-1 gene.
RT-PCR confirmed the expression of canine MAdCAM-1 in the canine mesenteric lymph node, consistent with findings in the rat [7] , mouse [5] , and human [9] . Relatively low expression was found in the spleen, stomach, duodenum, colon, and peripheral lymph node (Fig. 2) . Human MAd-CAM-1 mRNA was expressed at the highest level in the small intestine, followed by colon and spleen [9] . Likewise, mouse MAdCAM-1 mRNA was shown to be most highly expressed in the mesenteric lymph node and Payer's patches, followed by spleen and peripheral lymph node [5] , and rat MAdCAM-1 mRNA is most highly expressed in the mesenteric lymph node, followed by Payer's patches [7] .
These studies show that, in agreement with findings in rat and mouse, MAdCAM-1 is expressed in gut-associated lymphoid tissue of the dog. This and the similarity in the sequences of the immunoglobulin-like domains suggest that this protein has a similar structure and function in these species. The present results should facilitate investigations on the physiological and pathological roles of MAdCAM-1 in immune responses and various disease states in dogs.
